MAPT and Alzheimer disease: We attempt to validate the association of sPDGFRβ/DCE-MRI to BBB dysfunction using QAlb and study the association of BBB dysfunction and routinely used AD-biomarkers in the CSF (i.e. amyloid-beta, tau).